Srinivas Ayyadevara
Concepts (298)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caenorhabditis elegans | 29 | 2024 | 131 | 5.310 |
Why?
| Alzheimer Disease | 11 | 2025 | 316 | 3.530 |
Why?
| Neurodegenerative Diseases | 5 | 2025 | 74 | 2.710 |
Why?
| Longevity | 13 | 2019 | 80 | 2.270 |
Why?
| Caenorhabditis elegans Proteins | 12 | 2019 | 53 | 1.980 |
Why?
| Aging | 6 | 2025 | 692 | 1.880 |
Why?
| Hippocampus | 3 | 2025 | 221 | 1.440 |
Why?
| Phosphatidylinositol 3-Kinases | 6 | 2016 | 139 | 1.310 |
Why?
| Phosphatidylinositol Phosphates | 3 | 2018 | 14 | 1.150 |
Why?
| Animals | 40 | 2025 | 13063 | 1.100 |
Why?
| Endoplasmic Reticulum Stress | 2 | 2025 | 41 | 1.070 |
Why?
| Cardiovascular Diseases | 2 | 2025 | 464 | 1.000 |
Why?
| Aspirin | 3 | 2017 | 112 | 0.950 |
Why?
| 14-3-3 Proteins | 2 | 2022 | 20 | 0.940 |
Why?
| Brain | 3 | 2023 | 1318 | 0.910 |
Why?
| Proteomics | 4 | 2025 | 313 | 0.850 |
Why?
| Oxidative Stress | 6 | 2012 | 770 | 0.840 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 6 | 0.820 |
Why?
| DNA | 3 | 2021 | 534 | 0.740 |
Why?
| Mitochondria | 1 | 2025 | 400 | 0.740 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2021 | 5 | 0.730 |
Why?
| Glutathione Transferase | 3 | 2006 | 172 | 0.720 |
Why?
| RNA | 1 | 2021 | 164 | 0.680 |
Why?
| Chromosome Mapping | 4 | 2006 | 143 | 0.670 |
Why?
| Myocardial Infarction | 1 | 2023 | 402 | 0.660 |
Why?
| RNA Interference | 7 | 2016 | 179 | 0.650 |
Why?
| Somatomedins | 1 | 2018 | 28 | 0.610 |
Why?
| Mutation | 6 | 2016 | 1275 | 0.600 |
Why?
| Membrane Proteins | 3 | 2018 | 337 | 0.590 |
Why?
| Proteins | 2 | 2018 | 340 | 0.580 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.530 |
Why?
| Muscles | 1 | 2016 | 104 | 0.520 |
Why?
| Insulin | 1 | 2018 | 464 | 0.510 |
Why?
| Aldehydes | 2 | 2006 | 81 | 0.500 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2018 | 116 | 0.470 |
Why?
| Amyloid beta-Peptides | 4 | 2021 | 65 | 0.470 |
Why?
| Quantitative Trait Loci | 2 | 2006 | 42 | 0.470 |
Why?
| Lipids | 2 | 2016 | 151 | 0.460 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 104 | 0.440 |
Why?
| Disease Models, Animal | 7 | 2025 | 1431 | 0.430 |
Why?
| Humans | 25 | 2025 | 50419 | 0.430 |
Why?
| Mice | 9 | 2025 | 5659 | 0.400 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 104 | 0.370 |
Why?
| Hypertension | 1 | 2016 | 545 | 0.350 |
Why?
| Animals, Genetically Modified | 4 | 2018 | 46 | 0.350 |
Why?
| Peptide Fragments | 3 | 2021 | 208 | 0.350 |
Why?
| Obesity | 1 | 2018 | 1123 | 0.340 |
Why?
| Autophagy | 3 | 2024 | 168 | 0.340 |
Why?
| Signal Transduction | 4 | 2018 | 1608 | 0.320 |
Why?
| Polymerase Chain Reaction | 2 | 2000 | 447 | 0.310 |
Why?
| Lipid Peroxidation | 2 | 2007 | 96 | 0.310 |
Why?
| Gene Expression Regulation | 3 | 2011 | 948 | 0.310 |
Why?
| Codon, Nonsense | 3 | 2016 | 26 | 0.300 |
Why?
| Protein Binding | 4 | 2018 | 648 | 0.290 |
Why?
| Genetic Markers | 3 | 2003 | 104 | 0.260 |
Why?
| Transcription, Genetic | 5 | 2015 | 354 | 0.260 |
Why?
| Molecular Dynamics Simulation | 2 | 2017 | 34 | 0.250 |
Why?
| Receptor, Insulin | 1 | 2005 | 37 | 0.250 |
Why?
| Growth Inhibitors | 1 | 2005 | 26 | 0.250 |
Why?
| Phosphorylation | 2 | 2017 | 520 | 0.240 |
Why?
| Mitochondrial Dynamics | 1 | 2025 | 20 | 0.240 |
Why?
| Cell Death | 2 | 2016 | 175 | 0.230 |
Why?
| Lysosomes | 3 | 2024 | 83 | 0.230 |
Why?
| Kidney Tubules | 2 | 2017 | 61 | 0.230 |
Why?
| Quantitative Trait, Heritable | 2 | 2001 | 14 | 0.220 |
Why?
| Cryoprotective Agents | 1 | 2024 | 8 | 0.220 |
Why?
| Heat-Shock Proteins | 2 | 2023 | 96 | 0.220 |
Why?
| Activating Transcription Factor 6 | 1 | 2023 | 16 | 0.220 |
Why?
| Cryopreservation | 1 | 2024 | 33 | 0.210 |
Why?
| Hydrogen Peroxide | 2 | 2016 | 112 | 0.210 |
Why?
| Exosomes | 1 | 2023 | 47 | 0.210 |
Why?
| Amino Acid Sequence | 2 | 2021 | 575 | 0.200 |
Why?
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.200 |
Why?
| Benzylamines | 1 | 2021 | 15 | 0.180 |
Why?
| Huntington Disease | 1 | 2021 | 23 | 0.180 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 160 | 0.180 |
Why?
| Cholinesterase Inhibitors | 1 | 2021 | 24 | 0.180 |
Why?
| Alkaloids | 1 | 2021 | 28 | 0.180 |
Why?
| Protein Folding | 1 | 2021 | 45 | 0.180 |
Why?
| Male | 7 | 2025 | 25866 | 0.180 |
Why?
| Myocardium | 1 | 2023 | 443 | 0.180 |
Why?
| Taq Polymerase | 1 | 2000 | 4 | 0.180 |
Why?
| Base Pair Mismatch | 1 | 2000 | 21 | 0.170 |
Why?
| Indoles | 2 | 2020 | 277 | 0.170 |
Why?
| RNA, Viral | 1 | 2021 | 107 | 0.170 |
Why?
| Oxyquinoline | 1 | 2020 | 8 | 0.170 |
Why?
| Chelating Agents | 1 | 2020 | 28 | 0.170 |
Why?
| Neuroprotective Agents | 1 | 2021 | 97 | 0.170 |
Why?
| Mice, Inbred C57BL | 2 | 2023 | 1796 | 0.170 |
Why?
| Recombination, Genetic | 1 | 2001 | 102 | 0.170 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 89 | 0.170 |
Why?
| Glioma | 1 | 2021 | 74 | 0.170 |
Why?
| RNA-Binding Proteins | 1 | 2021 | 116 | 0.170 |
Why?
| Drug Design | 1 | 2020 | 119 | 0.160 |
Why?
| Proteome | 1 | 2021 | 161 | 0.160 |
Why?
| Models, Animal | 3 | 2019 | 225 | 0.160 |
Why?
| Hot Temperature | 2 | 2012 | 197 | 0.160 |
Why?
| Computer Simulation | 2 | 2017 | 273 | 0.150 |
Why?
| Ubiquitin | 2 | 2018 | 45 | 0.150 |
Why?
| Cells, Cultured | 4 | 2016 | 1563 | 0.150 |
Why?
| Gene Regulatory Networks | 1 | 2019 | 106 | 0.150 |
Why?
| DNA-Binding Proteins | 1 | 2021 | 410 | 0.150 |
Why?
| Cell Line | 2 | 2018 | 997 | 0.150 |
Why?
| Forkhead Transcription Factors | 3 | 2009 | 110 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 134 | 0.140 |
Why?
| Aged | 2 | 2025 | 9738 | 0.140 |
Why?
| Genotype | 4 | 2017 | 525 | 0.140 |
Why?
| Nucleotide Motifs | 1 | 2017 | 21 | 0.140 |
Why?
| Replication Origin | 1 | 2017 | 8 | 0.140 |
Why?
| RNA, Transfer | 1 | 2017 | 13 | 0.140 |
Why?
| Telomerase | 1 | 2017 | 25 | 0.140 |
Why?
| Acetylation | 1 | 2017 | 94 | 0.140 |
Why?
| Mice, Transgenic | 1 | 2018 | 537 | 0.140 |
Why?
| Complement C1q | 1 | 2017 | 6 | 0.140 |
Why?
| Carrier Proteins | 1 | 2018 | 297 | 0.140 |
Why?
| Pericytes | 1 | 2017 | 13 | 0.140 |
Why?
| Complement Activation | 1 | 2017 | 23 | 0.130 |
Why?
| Complement C3 | 1 | 2017 | 20 | 0.130 |
Why?
| Transcriptome | 1 | 2019 | 314 | 0.130 |
Why?
| Young Adult | 2 | 2016 | 4075 | 0.130 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 11 | 0.130 |
Why?
| Detergents | 1 | 2016 | 15 | 0.130 |
Why?
| Thermodynamics | 1 | 2016 | 33 | 0.130 |
Why?
| tau Proteins | 1 | 2016 | 29 | 0.130 |
Why?
| Promoter Regions, Genetic | 2 | 2011 | 455 | 0.130 |
Why?
| Catalytic Domain | 1 | 2016 | 57 | 0.130 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 110 | 0.130 |
Why?
| DNA Replication | 1 | 2017 | 155 | 0.130 |
Why?
| Solubility | 1 | 2016 | 71 | 0.130 |
Why?
| Blotting, Western | 2 | 2014 | 575 | 0.130 |
Why?
| Pyridinium Compounds | 1 | 2015 | 21 | 0.130 |
Why?
| Ligands | 1 | 2016 | 203 | 0.130 |
Why?
| Cyclin-Dependent Kinases | 1 | 2015 | 26 | 0.120 |
Why?
| Tissue Distribution | 1 | 2016 | 167 | 0.120 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.120 |
Why?
| Homologous Recombination | 1 | 2015 | 41 | 0.120 |
Why?
| Antineoplastic Agents | 2 | 2015 | 1165 | 0.120 |
Why?
| Benzimidazoles | 1 | 2015 | 49 | 0.120 |
Why?
| Reference Values | 1 | 2016 | 302 | 0.120 |
Why?
| Peptide Nucleic Acids | 1 | 2015 | 18 | 0.120 |
Why?
| Rad51 Recombinase | 1 | 2015 | 23 | 0.120 |
Why?
| Alleles | 2 | 2009 | 252 | 0.120 |
Why?
| Transcription Factors | 3 | 2009 | 561 | 0.120 |
Why?
| Fertility | 1 | 2014 | 28 | 0.120 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 109 | 0.120 |
Why?
| Stress, Physiological | 3 | 2011 | 171 | 0.110 |
Why?
| Protein Multimerization | 1 | 2014 | 50 | 0.110 |
Why?
| Melphalan | 1 | 2015 | 177 | 0.110 |
Why?
| Genes, Helminth | 2 | 2006 | 5 | 0.110 |
Why?
| Kidney | 2 | 2024 | 690 | 0.110 |
Why?
| Macrophages | 1 | 2017 | 365 | 0.110 |
Why?
| Renal Insufficiency, Chronic | 1 | 2017 | 173 | 0.110 |
Why?
| Models, Molecular | 3 | 2020 | 333 | 0.110 |
Why?
| Case-Control Studies | 1 | 2016 | 1152 | 0.100 |
Why?
| Drug Resistance, Neoplasm | 1 | 2015 | 315 | 0.100 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 186 | 0.100 |
Why?
| Age Factors | 1 | 2016 | 1118 | 0.100 |
Why?
| Life Expectancy | 1 | 2012 | 33 | 0.100 |
Why?
| Lipoprotein Lipase | 1 | 2012 | 13 | 0.100 |
Why?
| Endothelial Cells | 2 | 2011 | 256 | 0.100 |
Why?
| Locomotion | 1 | 2012 | 84 | 0.100 |
Why?
| Scavenger Receptors, Class E | 2 | 2011 | 203 | 0.090 |
Why?
| Microscopy, Confocal | 1 | 2012 | 84 | 0.090 |
Why?
| Down-Regulation | 2 | 2011 | 338 | 0.090 |
Why?
| Fluorescent Dyes | 1 | 2012 | 106 | 0.090 |
Why?
| Data Mining | 1 | 2011 | 39 | 0.090 |
Why?
| Triglycerides | 1 | 2012 | 160 | 0.090 |
Why?
| Antimitotic Agents | 1 | 2010 | 4 | 0.090 |
Why?
| Oxidants | 1 | 2011 | 51 | 0.090 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2011 | 82 | 0.090 |
Why?
| Multiple Myeloma | 2 | 2015 | 2990 | 0.090 |
Why?
| Adult | 2 | 2016 | 13561 | 0.090 |
Why?
| Cisplatin | 1 | 2012 | 283 | 0.090 |
Why?
| Fatty Acids | 1 | 2011 | 145 | 0.080 |
Why?
| Histoplasma | 1 | 2009 | 27 | 0.080 |
Why?
| Time Factors | 4 | 2019 | 2933 | 0.080 |
Why?
| Lipoproteins, LDL | 1 | 2011 | 170 | 0.080 |
Why?
| Epistasis, Genetic | 2 | 2017 | 29 | 0.080 |
Why?
| Angiogenesis Inhibitors | 1 | 2010 | 183 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2016 | 3233 | 0.080 |
Why?
| Histoplasmosis | 1 | 2009 | 50 | 0.080 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2007 | 133 | 0.080 |
Why?
| Evolution, Molecular | 1 | 2009 | 86 | 0.080 |
Why?
| Gene Expression | 2 | 2012 | 605 | 0.080 |
Why?
| Atherosclerosis | 1 | 2011 | 216 | 0.080 |
Why?
| Binding Sites | 1 | 2009 | 362 | 0.080 |
Why?
| Acute Kidney Injury | 1 | 2012 | 302 | 0.070 |
Why?
| Survival Rate | 1 | 2011 | 906 | 0.070 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 400 | 0.070 |
Why?
| Oxygen | 1 | 2010 | 319 | 0.070 |
Why?
| Oogenesis | 1 | 2007 | 16 | 0.070 |
Why?
| Female | 3 | 2025 | 27053 | 0.070 |
Why?
| Cell Proliferation | 1 | 2011 | 980 | 0.070 |
Why?
| DNA Methylation | 1 | 2011 | 548 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2021 | 1369 | 0.070 |
Why?
| Genes, Insect | 1 | 2006 | 11 | 0.070 |
Why?
| Drosophila melanogaster | 1 | 2006 | 29 | 0.070 |
Why?
| Cell Line, Tumor | 3 | 2015 | 1393 | 0.060 |
Why?
| Environment | 1 | 2006 | 80 | 0.060 |
Why?
| Models, Biological | 1 | 2009 | 717 | 0.060 |
Why?
| Apoptosis | 1 | 2011 | 1092 | 0.060 |
Why?
| Isoenzymes | 1 | 2005 | 165 | 0.060 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2015 | 210 | 0.060 |
Why?
| Up-Regulation | 2 | 2011 | 446 | 0.060 |
Why?
| Stress, Psychological | 1 | 2006 | 268 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 178 | 0.060 |
Why?
| Disease Progression | 2 | 2017 | 825 | 0.060 |
Why?
| Hormesis | 1 | 2024 | 8 | 0.060 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.060 |
Why?
| RNA, Messenger | 3 | 2017 | 1085 | 0.060 |
Why?
| Cytokines | 2 | 2017 | 602 | 0.060 |
Why?
| Animals, Congenic | 1 | 2003 | 3 | 0.050 |
Why?
| Animals, Inbred Strains | 1 | 2003 | 5 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2024 | 173 | 0.050 |
Why?
| Cell Survival | 2 | 2015 | 587 | 0.050 |
Why?
| Electrophorus | 1 | 2021 | 5 | 0.050 |
Why?
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.050 |
Why?
| Acetylcholinesterase | 1 | 2021 | 18 | 0.050 |
Why?
| Middle Aged | 1 | 2016 | 12579 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 831 | 0.050 |
Why?
| Horses | 1 | 2021 | 46 | 0.050 |
Why?
| Phenotype | 2 | 2017 | 736 | 0.050 |
Why?
| Lasers | 1 | 2021 | 106 | 0.050 |
Why?
| Crosses, Genetic | 1 | 2001 | 31 | 0.050 |
Why?
| Homozygote | 1 | 2001 | 57 | 0.040 |
Why?
| Biological Assay | 1 | 2021 | 45 | 0.040 |
Why?
| Heterozygote | 1 | 2001 | 83 | 0.040 |
Why?
| Templates, Genetic | 1 | 2000 | 13 | 0.040 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.040 |
Why?
| Food Deprivation | 1 | 2000 | 30 | 0.040 |
Why?
| Peptides | 1 | 2021 | 220 | 0.040 |
Why?
| Molecular Structure | 1 | 2021 | 293 | 0.040 |
Why?
| Protein Structure, Secondary | 1 | 2020 | 71 | 0.040 |
Why?
| DNA Transposable Elements | 1 | 2000 | 101 | 0.040 |
Why?
| DNA Primers | 1 | 2000 | 205 | 0.040 |
Why?
| Polymorphism, Genetic | 1 | 2001 | 177 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 391 | 0.040 |
Why?
| HEK293 Cells | 1 | 2020 | 209 | 0.040 |
Why?
| Dipyrone | 1 | 2019 | 2 | 0.040 |
Why?
| Anisomycin | 1 | 2019 | 3 | 0.040 |
Why?
| Camptothecin | 1 | 2019 | 15 | 0.040 |
Why?
| Benzazepines | 1 | 2019 | 20 | 0.040 |
Why?
| Azacitidine | 1 | 2019 | 34 | 0.040 |
Why?
| Protein Unfolding | 1 | 2018 | 6 | 0.040 |
Why?
| Protein Conformation | 1 | 2018 | 163 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 855 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 462 | 0.040 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.040 |
Why?
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2017 | 73 | 0.040 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 71 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2017 | 71 | 0.030 |
Why?
| Wnt3A Protein | 1 | 2017 | 10 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 19 | 0.030 |
Why?
| Extracellular Matrix Proteins | 1 | 2017 | 66 | 0.030 |
Why?
| Cell Communication | 1 | 2017 | 70 | 0.030 |
Why?
| Ureteral Obstruction | 1 | 2017 | 57 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2017 | 110 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2017 | 85 | 0.030 |
Why?
| Fibrosis | 1 | 2017 | 181 | 0.030 |
Why?
| Indolizines | 1 | 2015 | 5 | 0.030 |
Why?
| Cyclic N-Oxides | 1 | 2015 | 12 | 0.030 |
Why?
| Folic Acid | 1 | 2017 | 141 | 0.030 |
Why?
| Drug Synergism | 1 | 2015 | 149 | 0.030 |
Why?
| Mice, SCID | 1 | 2015 | 171 | 0.030 |
Why?
| S Phase | 1 | 2015 | 18 | 0.030 |
Why?
| Genes, BRCA1 | 1 | 2015 | 19 | 0.030 |
Why?
| Mice, Knockout | 1 | 2017 | 840 | 0.030 |
Why?
| DNA Damage | 1 | 2015 | 299 | 0.030 |
Why?
| Receptors, Lipoprotein | 1 | 2012 | 7 | 0.020 |
Why?
| Azo Compounds | 1 | 2012 | 10 | 0.020 |
Why?
| Angiopoietins | 1 | 2012 | 5 | 0.020 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 14 | 0.020 |
Why?
| Neutrophil Infiltration | 1 | 2012 | 24 | 0.020 |
Why?
| Coloring Agents | 1 | 2012 | 67 | 0.020 |
Why?
| Intracellular Space | 1 | 2012 | 25 | 0.020 |
Why?
| Melanins | 1 | 2012 | 26 | 0.020 |
Why?
| Adipose Tissue, White | 1 | 2012 | 34 | 0.020 |
Why?
| Necrosis | 1 | 2012 | 173 | 0.020 |
Why?
| Intercellular Junctions | 1 | 2010 | 8 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 151 | 0.020 |
Why?
| Antibodies, Neutralizing | 1 | 2011 | 62 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2010 | 82 | 0.020 |
Why?
| Body Weight | 1 | 2012 | 517 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 549 | 0.020 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 997 | 0.020 |
Why?
| Microscopy | 1 | 2009 | 58 | 0.020 |
Why?
| Cell Differentiation | 1 | 2012 | 640 | 0.020 |
Why?
| Virulence | 1 | 2009 | 160 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 134 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1020 | 0.020 |
Why?
| Liver | 1 | 2012 | 1126 | 0.020 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 2000 | 7 | 0.010 |
Why?
| Sequence Homology | 1 | 2000 | 15 | 0.010 |
Why?
| Larva | 1 | 2000 | 26 | 0.010 |
Why?
| Gene Library | 1 | 2000 | 39 | 0.010 |
Why?
| DNA, Complementary | 1 | 2000 | 134 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2000 | 190 | 0.010 |
Why?
|
|
Ayyadevara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|